Chembio Diagnostics Reports Third Quarter 2022 Financial Results
Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today
United States United Kingdom Richard Eberly Philip Taylor Company Nasdaq Reszon Diagnostics International
Source: einnews.com